Dynamics of inflammatory biomarkers in hospitalized patients with acute kidney injury during covid-19


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. identification of the features and dynamics of inflammatory biomarkers in patients with acute kidney injury in COVID-19. material and methods. the retrospective study included 437 patients admitted to an infectious diseases hospital with a confirmed diagnosis of covid-19. in dynamics, the serum creatinine, ferritin, lactate dehydrogenase (LDH), c-reactive protein (CRP) levels were assessed, the level of interleukin-6 (IL-6) was assessed at admission. acute kidney injury (AKI) was diagnosed according to the kdigo (2022) criteria. results. it was revealed that 76 (20.5%) examined patients had signs of aki. the crp, ferritin and ldh levels at admission and on the 3rd day after were higher in patients with aki, and on the 5th and ioth day only an increase in the ldh level remained statistically significant. the level of il-6 at admission was also higher in the group of patients with aki. conclusion. hospitalized patients with aki associated with covid-19 had higher plasma levels of inflammatory biomarkers. the high incidence of aki in the covid-19 hospitalized population necessitates monitoring of renal function parameters at the outpatient stage after discharge.

全文:

受限制的访问

作者简介

Svetlana Perepelitsa

Immanuel Kant Baltic Federal University; Federal Research Clinical Center of Intensive Care Medicine and Rehabilitology

Email: sveta_perepeliza@mail.ru
Dr.Sci. (Med.), Professor at the Department of Surgical Disciplines, Medical Institute, Immanuel Kant Baltic Federal University, Leading researcher at the V.A. Negovsky Research Institute of General Reanimatology, Federal Research Clinical Center of Intensive Care Medicine and Rehabilitology Kaliningrad, Russia; Moscow, Russia

Larisa Mikhailova

Immanuel Kant Baltic Federal University

Email: mihalysa@mail.ru
Cand. Sci. (Med.), Associate Professor, Department of Therapy, Medical Institute Kaliningrad, Russia

Kirill Shcherbanev

Immanuel Kant Baltic Federal University

Email: sherbanev1997@mail.ru
1st-year Resident in the specialty "Therapy", Medical Institute Kaliningrad, Russia

Fatima Yunusova

Immanuel Kant Baltic Federal University

Email: yunusovafati@yandex.ru
1st-year Resident in the specialty "Therapy", Medical Institute Kaliningrad, Russia

参考

  1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708-20.
  2. Cheng Y., Luo R., Wang K. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-38.
  3. Hirsch J.S., Ng J.H., Ross D.W. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209-18.
  4. Cummings M.J., Baldwin M.R., Abrams D. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763-70.
  5. Karagiannidis C., Mostert C., Hentschker C. Case characteristics, resource use, and outcomes of 10021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir. Med. 2020;8:853-62.
  6. Coca A., Burballa C., Centellas-Pérez F.J., et al. Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD. Front. Med. (Lausanne). 2020;7:615312. Published 2020 Dec 3. doi: 10.3389/fmed.2020.615312.
  7. Gross O., Moerer O., Weber M. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020;395:e87-8.
  8. Werion A., Belkhir L., Perrot M. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int. 2020;98:1296-307.
  9. Braun F., Lütgehetmann M., Pfefferle S. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. 2020;396:597-98.
  10. Kudose S., Batal I., Santoriello D. Kidney biopsy findings in patients with COVID-19. J. Am. Soc. Nephrol. 2020;31:1959-68.
  11. Sharma P., Uppal N.N., Wanchoo R. COVID-19-associated kidney injury: a case series of kidney biopsy findings. J. Am. Soc. Nephrol. 2020;31:1948-58.
  12. Santoriello D., Khairallah P., Bomback A.S. Postmortem kidney pathology findings in patients with COVID-19. J. Am. Soc. Nephrol. 2020;31:2158-67.
  13. Ng J.H., Hirsch J.S., Hazzan A. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am. J. Kidney Dis. 2021;77(2):204-15.
  14. Gupta S., Coca S.G., Chan L. AKI treated with renal replacement therapy in critically ill patients with COVID-19. J. Am. Soc. Nephrol. 2021;32:161-76.
  15. Fisher M., Neugarten J., Bellin E. AKI in hospitalized patients with and without COVID-19: a comparison study. J. Am. Soc. Nephrol. 2020;31:2145-57.
  16. Li X., Geng M., Peng Y., et al. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020;10(2):102-8. doi: 10.1016/j.jpha.2020.03.001.
  17. Del Vecchio L., Locatelli F. Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19. Clin. Kidney J. 2020;13(4):494-99.
  18. Chen J., Wang W., Tang Y., et al. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury.Int. J. Biol. Sci. 2021;17(6):1497-506. Published2021 Apr 10. doi: 10.7150/ijbs.58791.
  19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter. Suppl. 2012;1:1-126.
  20. Qin C., Zhou L., Hu Z., et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China. Clin. Infect. Dis. 2020;71(15):762-68.
  21. Mehta P., McAuley D.F., Brown M., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-34.
  22. Zhu Z., Cai T., Fan L., et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.Int. J. Infect. Dis. 2020;95:332-39.
  23. Gao Y., Li T., Han M., et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 2020;92(7):791-96.
  24. Henry B.M., Aggarwal G., Wong, J., et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am. J. Emerg. Med. 2020;38(9):1722-26. doi: 10.1016/j.ajem.2020.05.073.
  25. Moshage H. Cytokines and the hepatic acute phase response. J. Pathol. 1997;181(3):257-66.
  26. Ruscitti P., Berardicurti O., Barile A., et al. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann. Rheum. Dis. 2020;79(11):1515-16.
  27. Poggiali, E., Zaino, D., Immovilli, P., et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.Int. J. Clin. Chem. 2020;509:135-38. doi: 10.1016/j.cca.2020.06.012.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##